Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 1:51 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 1,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Trauma Injury, Physician's Role
Interventions: Night Shift, Usual education; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 25 Years to 70 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Kidney Failure, Kidney Transplant; Complications, Chimera
Interventions: Bone Marrow Transplant, Peripheral Blood Stem Cell Collection, Fludarabine, Cyclophosphamide, Rituximab, Siplizumab; Other · Procedure · Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2032
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer
Interventions: Digital PET/CT scan; Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Anemia, Iron Deficiency Anemia
Interventions: Treatment with oral sucrosomial iron, Treatment with intravenous iron; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Tissue Expansion, Breast Reconstruction
Interventions: Tissue Expansion; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: ACL Injury, Anterior Cruciate Ligament Injuries
Interventions: Video-Based Intervention, Classroom-Based Intervention; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 15 Years to 65 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Hyperglycemia
Interventions: Sitagliptin, Placebo, Supplemental insulin (insulin lispro), Supplemental insulin (insulin aspart), Long acting basal insulin (insulin detemir), Long acting basal insulin (insulin glargine); Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Crohn Disease
Interventions: Radiotracer Injection, Contrast Media, Magnetic Resonance, Blood Draw, Glucagon, Imaging, Oral contrast media application; Drug · Diagnostic Test
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 99 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Cancer
Interventions: Telephone Intervention, Questionnaires & Interviews; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cesarean Section, Anesthesia, Obstetric
Interventions: Intrathecal 1.6 ml 0.75% bupivacaine in 8.25% dextrose combined with 15 mcg fentanyl and 150 mcg preservative-free morphine; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 15 Years to 55 Years · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Opioid Use Disorder, Posttraumatic Stress Disorder
Interventions: Prolonged exposure therapy, Financial incentives, Treatment as usual; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Cancer, Solid Tumor, Patient Empowerment, Telemedicine
Interventions: Text triage; Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Oropharyngeal Squamous Cell Carcinoma
Interventions: CUE-101; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hearing Loss
Interventions: Current Primary Care Referral Process, Telemedicine Referral Process; Other
Lead sponsor: Norton Sound Health Corporation; Other
Eligibility: 2 Years to 6 Years
Enrollment: 155 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Nome, Alaska

Conditions: Metastatic Castration-resistant Prostate Cancer
Interventions: 3'-Deoxy-3'-[18F]-fluorothymidine, Chemical-shift-encoded MRI; Drug · Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Hidradenitis Suppurativa (HS)
Interventions: Radiated axilla; Radiation
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Cherry Hill, New Jersey • Philadelphia, Pennsylvania

Conditions: Leukemia, Myeloid Leukemia, Monocytic Leukemia
Interventions: Venetoclax, Azacitidine, Mitoxantrone; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Cataract
Interventions: Mandatory On-Site Pre-Admission Testing; Behavioral
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years and older
Enrollment: 442 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Well Child Visit, Gaps in Care
Interventions: Automated SMS, Automated SMS + Conversational AI Scheduling Assistance, Traditional Passive Outreach; Behavioral · Other
Lead sponsor: Waymark; Industry
Eligibility: 0 Years to 21 Years
Enrollment: 2,821 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: filgrastim, PR104, F-18-fluoromisonidazole; Biological · Drug · Other
Lead sponsor: Proacta, Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Scottsdale, Arizona • San Antonio, Texas

Conditions: Cortical Blindness
Interventions: Multisensory Rehabilitation; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Blood Pressure
Interventions: Multidimensional Sleep Health Promotion Intervention; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 30 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Suicidal Ideation, Suicide Attempt, Anxiety, Depression Disorders
Interventions: Peer Support Services Recovery; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 27 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Depression, Pregnancy
Interventions: Intervention, Control; Other
Lead sponsor: Lancaster General Hospital; Other
Eligibility: 13 Years and older · Female only
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 4
States / cities: Lancaster, Pennsylvania • Philadelphia, Pennsylvania

Search by objective public record fields.

Testing the Effectiveness of Night Shift, a Theory-based Customized Video Game

Delayed Tolerance Through Mixed Chimerism

Standard PET/CT vs. Digital PET/CT

Sucrosomial Vs Intravenous Iron for Preoperative Anemia

Patient Performed Tissue Expansion for Two-stage Alloplastic Breast Reconstruction

Comparing Perioperative Education Modalities for ACL Reconstruction on Patient Satisfaction, Self-Efficacy, and Surgical Outcomes

Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

Identification and Treatment of Depression

Evaluation of the Typical Spinal Block During Cesarean Delivery

Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD

Text-based Intervention to Minimize the Time Burden of Routine Cancer Care

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

Reducing Childhood Hearing Loss in Rural Alaska Through a Preschool Screening and Referral Process Using Mobile Health and Telemedicine

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

Radiotherapy for Refractory Hidradenitis Suppurativa

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation

A Trial of AI-Powered Text Message Outreach on Well-Child Visit Completion

PR104 and G-CSF in Treating Patients With Solid Tumors

Multisensory Rehabilitation of Vision Loss After Cortical Damage

The DREAM Study: A Multidimensional Sleep Health Intervention for Improving Cardiometabolic Health

Recovery Through Inspiration, Support, and Empowerment

Care Managers for Perinatal Depression (CMPD)